Adherence to Antipsychotics in Schizophrenia
Poor adherence to therapy is one of the main obstacles to treatment effectiveness in schizophrenia. It is the main determinant of relapse, hospitalization, symptom persistence, and poor psychosocial functioning and outcome. Adherence to treatment is affected by various factors related to the disease...
| Published in: | Springer eBooks |
|---|---|
| Main Authors: | , , , |
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Milano :
Springer Milan : Imprint: Springer,
2014.
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1007/978-88-470-2679-7 Перейти в каталог НБ ТГУ |
| LEADER | 04744nam a22005655i 4500 | ||
|---|---|---|---|
| 001 | vtls000545976 | ||
| 003 | RU-ToGU | ||
| 005 | 20210922083513.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 160915s2014 it | s |||| 0|eng d | ||
| 020 | |a 9788847026797 |9 978-88-470-2679-7 | ||
| 024 | 7 | |a 10.1007/978-88-470-2679-7 |2 doi | |
| 035 | |a to000545976 | ||
| 039 | 9 | |y 201609152243 |z Александр Эльверович Гилязов | |
| 040 | |a Springer |c Springer |d RU-ToGU | ||
| 050 | 4 | |a RC434.2-574 | |
| 072 | 7 | |a MMH |2 bicssc | |
| 072 | 7 | |a MED105000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.89 |2 23 |
| 100 | 1 | |a Sacchetti, Emilio. |e author. |9 454791 | |
| 245 | 1 | 0 | |a Adherence to Antipsychotics in Schizophrenia |h electronic resource |c by Emilio Sacchetti, Antonio Vita, Alberto Siracusano, Wolfgang Fleischhacker. |
| 260 | |a Milano : |b Springer Milan : |b Imprint: Springer, |c 2014. |9 742227 | ||
| 300 | |a XII, 159 p. 10 illus., 1 illus. in color. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 505 | 0 | |a 1 Poor adherence to antipsychotic medication in people with schizophrenia: diffusion, consequences, and contributing factors -- Premise -- Role of antipsychotics in the treatment of schizophrenia -- Compliance versus adherence -- Assessment of medication adherence -- Frequency of poor adherence to antipsychotics -- Consequences of poor adherence to antipsychotics -- Determinants and moderators of adherence to antipsychotics -- Present and medium-term perspectives -- Closing Remarks -- 2 Pharmacological strategies to enhance adherence in schizophrenia -- Introduction -- Pharmacological factors contributing to non-adherence: efficacy, side effects, regimen, co-therapies -- First vs Second generation antipsychotics: efficacy, tolerability and the adherence issue -- Long-acting injectable antipsychotics -- Conclusion. 3 Non-pharmacological strategies to enhance adherence and continuity of care in schizophrenia -- Introduction -- Factors Influencing (non-)adherence in Schizophrenia -- Interventions to Enhance Adherence. Research and Clinical Evidence -- Comprehensive Review of Psychosocial and Programmatic Interventions to Enhance Adherence to Antipsychotic Medication in Schizophrenia -- Summary of Main Results and Evidences -- Conclusions and Future Directions -- 4 Psychological issues in improving adherence and alliance -- The patient-doctor relationship as a determinant of adherence to treatment -- Alliance and psychodynamic issues -- Towards the concept of concordance of the therapeutic project. | |
| 520 | |a Poor adherence to therapy is one of the main obstacles to treatment effectiveness in schizophrenia. It is the main determinant of relapse, hospitalization, symptom persistence, and poor psychosocial functioning and outcome. Adherence to treatment is affected by various factors related to the disease characteristics, to the patient him- or herself, to the treatment, and to the therapeutic relationship. Some of these factors are modifiable, and both pharmacological and non-pharmacological strategies have been developed for this purpose. This book addresses the different aspects of adherence to treatment in schizophrenia and related disorders in a systematic but easy-to-use manual format. Chapters focus on a full range of issues, including pharmacological and non-pharmacological strategies to enhance adherence and continuity of care, relevant psychological factors, the importance of the patient-doctor relationship, and the need for an alliance with other care-givers. Adherence to Antipsychotics in Schizophrenia will be an invaluable asset for all who are involved in the care of patients with schizophrenia. | ||
| 650 | 0 | |a medicine. |9 566220 | |
| 650 | 0 | |a Neurosciences. |9 302217 | |
| 650 | 0 | |a Toxicology. |9 302218 | |
| 650 | 0 | |a Psychiatry. |9 566321 | |
| 650 | 0 | |a Psychopharmacology. |9 302319 | |
| 650 | 0 | |a Psychotherapy. |9 308578 | |
| 650 | 1 | 4 | |a Medicine & Public Health. |9 566221 |
| 650 | 2 | 4 | |a Psychiatry. |9 566321 |
| 650 | 2 | 4 | |a Psychopharmacology. |9 302319 |
| 650 | 2 | 4 | |a Psychotherapy. |9 308578 |
| 650 | 2 | 4 | |a Neurosciences. |9 302217 |
| 650 | 2 | 4 | |a Pharmacology/Toxicology. |9 302222 |
| 700 | 1 | |a Vita, Antonio. |e author. |9 454793 | |
| 700 | 1 | |a Siracusano, Alberto. |e author. |9 454794 | |
| 700 | 1 | |a Fleischhacker, Wolfgang. |e author. |9 454795 | |
| 710 | 2 | |a SpringerLink (Online service) |9 143950 | |
| 773 | 0 | |t Springer eBooks | |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/978-88-470-2679-7 |
| 856 | |y Перейти в каталог НБ ТГУ |u https://koha.lib.tsu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=403751 | ||
| 912 | |a ZDB-2-SME | ||
| 950 | |a Medicine (Springer-11650) | ||
| 999 | |c 403751 |d 403751 | ||